Lifecore Biomedical, Inc. Common Stock earnings per share and revenue
On 02 de jan. de 2026, LFCR reported earnings of -- USD per share (EPS) for Q2 26, -- the estimate of -0.19 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 32.99 milhão, with a --% difference.
Looking ahead to Q3 26, 7 analistas forecast an EPS of -0.22 USD, with revenue projected to reach 32.20 milhão USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
What were Lifecore Biomedical, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Lifecore Biomedical, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Lifecore Biomedical, Inc. Common Stock's Q2 2026 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Lifecore Biomedical, Inc. Common Stock expected to report next?
The next earning report is scheduled for 01 de abr. de 2026.
What are the forecasts for Lifecore Biomedical, Inc. Common Stock's next earnings report?
Based on 7
analistas, Lifecore Biomedical, Inc. Common Stock is expected to report EPS of -$0.22 and revenue of $32.20M for Q3 2026.